This week: The approval of a second COVID-19 vaccine; Pfizer and BioNTech submit for Emergency Use of their vaccine for children under 5; Pfizer also stop development on a potential drug treatment to reduce cardiovascular risk and severe hypertriglyceridemia; And a HIV drug gets new dosing option.